MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Chairperson's File
This week brings the fourth week of the federal government shutdown as Congress has yet to pass legislation to fund the government. This shutdown is a bit…
Headline
An article in the October edition of AHA Trustee Insights explains how boards can effectively lead aging care efforts as the nation’s population grows older…
Headline
The AHA has released a social media toolkit in advance of National Rural Health Day Nov. 20 that includes advocacy-focused posts for hospitals and health…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
AHA says revised H-1B selection process could hinder hospital efforts to address workforce shortages
The AHA commented Oct. 24 on the Department of Homeland Security’s proposed weighted selection process for registrants and petitioners participating in the H-…
Perspective
Getting an annual flu vaccination is the best way to prevent flu and its potentially serious complications. The Centers for Disease Control and Prevention…